TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Biogen at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Biogen takes part in 3 sessions at TIDES Europe 2026 in Amsterdam. Its sessions focus on oligonucleotide CMC for antisense drug products. They weigh cost, productivity and safety in manufacturing, how formulation and regulatory expectations shape steam sterilization, and a comprehensive approach to controlling impurities across purification.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Biogen Cambridge, MA | |
Biopharmaceutical company developing and marketing neuroscience medicines, including antisense oligonucleotide treatments. | Talk Tue Nov 3 10:45–11:00 Talk Wed Nov 4 10:15–10:45 Finding the Right Balance: How Formulation Aspects and Regulatory Expectations Affect Steam Sterilization of Antisense Oligonucleotide (ASO) Drug Products Whether antisense drug products can survive steam sterilisation, and how the liquid formula and container can be tuned so regulators accept it. Talk Thu Nov 5 08:05–08:35 Strategies for Implementing a Comprehensive Impurity Control Approach Across Oligonucleotide Purification Process A risk-based plan for clearing unwanted by-products, solvents and bacterial toxins from an oligonucleotide drug during two purification steps and filtration. |
Find decision makers at Biogen
Tell us what you sell and we’ll find the people at Biogen most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction